Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00001021||Completed||A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)||
||NIH / Industry||
||57||All||18 Years to 60 Years (Adult)||NCT00001021||AVEG 009
|August 31, 2001||June 24, 2005||